Elanco

$32.86
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.13 (+3.56%) Today
$0.00 (0.00%) As of 11:00 PM UTC after-hours

Why Robinhood?

You can buy or sell Elanco and other stocks, options, and ETFs commission-free!

About ELAN

Elanco Animal Health, Inc. engages in the innovation, development, manufacture and market products for companion and food animals. It offers products through the following four categories: Companion Animal Disease Prevention, Companion Animal Therapeutics, Food Animal Future Protein & Health, and Food Animal Ruminants & Swine. The Companion Animal Disease Prevention category engages in the broadest parasiticide portfolios in the companion animal sector based on indications, species and formulations, with products that protect pets from worms, fleas and ticks. The Companion Animal Therapeutics category provides the details of broad pain and osteoarthritis portfolio across species, modes of action, indications and disease stages. The Food Animal Future Protein & Health category includes vaccines, nutritional enzymes and animal-only antibiotics, serves the growing demand for protein and includes innovative products in poultry and aquaculture production, where demand for animal health products is outpacing overall industry growth. It also focuses on developing functional nutritional health products that promote food animal health, including enzymes, probiotics and prebiotics. The Food Animal Ruminants & Swine category develops animal food products used in ruminant and swine production. The company was founded on May 3, 2018 and is headquartered in Greenfield, IN. The listed name for ELAN is Elanco Animal Health Incorporated Common Stock.

CEO
Jeffrey N. Simmons
Employees
5,760
Headquarters
Greenfield, Indiana
Founded
1954
Market Cap
15.08B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
4.83M
High Today
$33.44
Low Today
$32.11
Open Price
$32.40
Volume
7.08M
52 Week High
$34.09
52 Week Low
$15.17

ELAN News

ReutersFeb 24

Edited Transcript of ELAN.N earnings conference call or presentation 24-Feb-21 1:00pm GMT

Q4 2020 Elanco Animal Health Inc Earnings Call Feb 25, 2021 (Thomson StreetEvents) -- Edited Transcript of Elanco Animal Health Inc earnings conference call or
BenzingaFeb 24

Recap: Elanco Animal Health Q4 Earnings

Shares of Elanco Animal Health (NYSE:ELAN) moved higher by 3.7% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per sh

ELAN Earnings

$0.06
$0.14
$0.22
$0.30
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
$0.09 per share
Actual
$0.12 per share
Replay Earnings Call

You May Also Like

CALM
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure